Keyphrases
Type 2 Diabetes Mellitus (T2DM)
100%
Depressive Symptoms
56%
Older Adults
51%
Cognitive Decline
40%
Depression Dimension
36%
Geriatric Depression Scale
36%
Apathy
36%
Haptoglobin
35%
Haptoglobin Genotype
30%
Ketamine
29%
Brain Volume
28%
Randomized Controlled Trial
28%
Major Depressive Disorder
22%
Diabetes
22%
Vitamin E Supplementation
21%
Cognitive Function
19%
Executive Function
19%
Treatment-resistant Depression
17%
Global Cognition
16%
Cognitive Status
15%
Cognitive Domains
14%
Alzheimer's Disease
14%
Chronic Traumatic Encephalopathy
14%
Speech Markers
14%
Tauopathy
14%
Cognitive Outcome
14%
Episodic Memory
12%
Antidepressants
12%
Israel
12%
Genotype
11%
Placebo
10%
Subjective Memory Complaints
10%
Semantic Categorization
10%
Suicidal Ideation
10%
Cognitive Impairment
10%
Non-carriers
9%
Pharmacotherapy
9%
Neuropsychiatric Symptoms
9%
Inferior Frontal Gyrus
9%
Dysphoric Mood
8%
Depression in Elderly
8%
Dysphoria
8%
Elderly People
8%
Fast Rates
8%
Functional Decline
8%
Rapid Reduction
7%
Treatment-resistant
7%
Middle Temporal Gyrus
7%
Quinidine
7%
Childhood Trauma
7%
Neuroscience
Geriatric Depression Scale
41%
Executive Function
36%
Haptoglobin
35%
Major Depressive Disorder
30%
Randomized Controlled Trial
29%
Depression
29%
Ketamine
28%
Episodic Memory
26%
Cognitive Function
22%
Vitamin E
21%
Cognitive Disorders
17%
Treatment-Resistant Depression
16%
Antidepressant
14%
Tauopathy
14%
Brain Disease
14%
Fluorine-18
12%
Working Memory
11%
Placebo
10%
Diabetes Mellitus
9%
Pediatric Trauma
7%
DNA Polymorphism
7%
Neuropeptide Y
7%
Neuropeptide
7%
Hemoglobin A1c
7%
Dextromethorphan Plus Quinidine
7%
Neuroticism
7%
Delusion
7%
Alzheimer's Disease
7%
Prazosin
7%
Dextromethorphan
5%
Gray Matter
5%